Atlas Trials

Expanded Access to Navitoclax

Clinical trial NCT03592576 · NO_LONGER_AVAILABLE

Trial details

NCT number
NCT03592576
Sponsor
AbbVie
Status
NO_LONGER_AVAILABLE
Study type
EXPANDED_ACCESS
MyelofibrosisAcute Lymphocytic Leukemia (ALL)Lymphoblastic Lymphoma

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.